U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07096674) titled 'A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia' on July 02.
Brief Summary: This study is a long-term extension (LTE) of the parent Study ORX750 0201, and will provide long-term open-label safety, tolerability, and efficacy of ORX750 in participants with narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH).
Study Start Date: July 31
Study Type: INTERVENTIONAL
Condition:
Narcolepsy Type 1
Narcolepsy Type 2
Idiopathic Hypersomnia
Intervention:
DRUG: ORX750
Oral ORX750
DRUG: ORX750
Oral ORX750
DRUG: ORX750
Oral ORX750
Recruitment Status: NOT_YET_RE...